
Sanofi Stock Down 1.6%, Company Is Criticized for Giving U.S. Priority Access to Its Vaccine
After closing yesterday with a 0.17% rise, Sanofi (SNY) stock is in the red now. “Giving the U.S. priority access to a Sanofi vaccine against the new coronavirus would be ‘unacceptable,’” a French government minister said.